| http://www.w3.org/ns/prov#value | - The program will exploit Genovis??? FeOdot technology, which the company claims represents a new class of nanoparticles that can be used as contrast agents in more than one type of medical imaging technique. ???The LUPAS project aims to combine MRT and optical measurement, where luminescent conjugated polymers, LCPs, a material normally used for electronic applications such as LEDs, will be a key
|
